| Literature DB >> 29531159 |
Chao Huang1,2, Zhe Zhang3, Lihan Chen2, Hank W Lee2, Marina K Ayrapetov4, Ting C Zhao4, Yimei Hao2, Jinsong Gao4, Chunzhang Yang5, Gautam U Mehta5, Zhengping Zhuang5, Xiaoren Zhang2, Guohong Hu2, Y Eugene Chin1,2.
Abstract
Posttranslational modifications of mammalian c-Src N-terminal and C-terminal domains regulate distinct functions. Myristoylation of G2 controls its cell membrane association and phosphorylation of Y419/Y527 controls its activation or inactivation, respectively. We provide evidence that Src-cell membrane association-dissociation and catalytic activation-inactivation are both regulated by acetylation. In EGF-treated cells, CREB binding protein (CBP) acetylates an N-terminal lysine cluster (K5, K7, and K9) of c-Src to promote dissociation from the cell membrane. CBP also acetylates the C-terminal K401, K423, and K427 of c-Src to activate intrinsic kinase activity for STAT3 recruitment and activation. N-terminal domain phosphorylation (Y14, Y45, and Y68) of STAT3 by c-Src activates transcriptionally active dimers of STAT3. Moreover, acetyl-Src translocates into nuclei, where it forms the Src-STAT3 enhanceosome for gene regulation and cancer cell proliferation. Thus, c-Src acetylation in the N-terminal and C-terminal domains play distinct roles in Src activity and regulation.Significance: CBP-mediated acetylation of lysine clusters in both the N-terminal and C-terminal regions of c-Src provides additional levels of control over STAT3 transcriptional activity. Cancer Res; 78(11); 2825-38. ©2018 AACR. ©2018 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29531159 DOI: 10.1158/0008-5472.CAN-17-2314
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701